Posted On: Friday, March 27th, 2015
Two new, often curative, hepatitis C drugs are now provided under British Columbia’s public drug plan coverage, Minister of Health Terry Lake announced on Monday, March 23, 2015. People with hepatitis C will be able to apply tomorrow for coverage under B.C.’s PharmaCare program of Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir). These new medications… Read more »
Posted On: Friday, March 20th, 2015
Posted On: Wednesday, March 18th, 2015
New and Noteworthy Holkira Pak cures 94% of people co-infected with Hep C and HIV High cure rates for Harvoni in people co-infected with HIV and Hep C Hep C testing program in an emergency department finds undiagnosed older adults with Hep C
Posted On: Friday, March 13th, 2015
Hepatitis C virus (HCV) infects the liver and, if left untreated, eventually causes serious injury to this vital organ, leading to complications, liver failure and, in some cases, liver cancer. In the past year, combinations of new and powerful oral medications to treat HCV have been licensed in Canada. To help doctors, nurses and other… Read more »
Posted On: Wednesday, March 11th, 2015
The number of treatment stories has been growing during the past 5 years as thousands of people have participated in clinical trials for hepatitis C Direct Acting Antivirals (DAAs). As data from these clinical trials continues to emerge, so do the personal treatment stories and experiences of people who have been treated with these new… Read more »
Posted On: Wednesday, March 11th, 2015
AVI presents a ‘Lunch & Learn’ on the topic of Hepatitis C for Healthcare and Service Providers. They will cover the basics of hepatitis C including testing, transmission, and community resources, followed by an update on current and upcoming treatments provided by treatment nurses. Light lunch and refreshments provided. Victoria: Wednesday March 25th 12:00pm-2:00pm Access… Read more »
Posted On: Wednesday, March 4th, 2015
New and Noteworthy P.E.I. announces their hepatitis C strategy Community-based program successful at linking people to Hep C testing and care
Posted On: Tuesday, February 24th, 2015
New and Noteworthy Vertical transmission of hepatitis C estimated to occur in over 5% of births in women with hepatitis C According to a systematic review on vertical transmission of hepatitis C, the estimated risk for transmission of hepatitis C to the fetus during pregnancy is 5.8%, reported researchers in Clinical Infectious Diseases. With hepatitis… Read more »
Posted On: Wednesday, February 11th, 2015
New and Noteworthy Screening Canadians born between 1945 and 1965 could be cost effective According to a modelling study, one-time screening for people 25 to 64 or 45 to 64 years of age could be cost-effective, reported researchers in the Canadian Medical Association Journal. For both age ranges the researchers modelled four options: No screening… Read more »
Posted On: Wednesday, February 11th, 2015
Posted On: Wednesday, January 28th, 2015
Friday, February 6, 2015 @1:00pm EST Join us for this webinar where we will present an overview of the 2012-2013 HIV and HCV Performance Measurement Reports. The reports cover activities funded through the national Voluntary Sector Fund; Knowledge Exchange Fund; On-Reserve First Nations, Inuit and Métis Communities HIV/AIDS Project Fund;and the Hepatitis C Prevention, Support… Read more »
Posted On: Wednesday, January 21st, 2015
New and noteworthy Holkira Pak (AbbVie 3D combination) approved by Health Canada Holkira Pak cures Hep C in most liver transplant recipients Birth cohort screening more effective than risk-based testing in U.S.
